HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice.

Abstract
The antiviral activity of Shigyaku-to (TJS-109), a traditional Chinese herbal medicine, was investigated in mice infected with herpes simplex virus type 1 (HSV-1). TJS-109 is a combination of the medicinal plant extracts from Zingiberis siccatum rhizoma, Aconiti tuber and Glycyrrhizae radix in a specific proportion. Mice infected with a 10 LD50 dose of HSV-1 were treated with TJS-109 orally at doses of 1.25 to 20 mg/kg 2 days before, and 1 and 4 days after the infection. The treated groups had 80% (1.25 mg/kg), 40% (5 mg/kg) and 23% (20 mg/kg) mortality rates 25 days after the infection as compared with a 100% mortality rate in control mice treated with saline. When HSV-1 infected mice (recipients) received CD8+ T cell fractions derived from spleens of mice treated with TJS-109 (donors), 70% of recipients survived, as compared with 0% survivors in the groups of mice treated with saline, B cell fractions, CD4+ T cell fractions or macrophage-enriched fractions prepared from the same donors. TJS-109 did not show any virucidal activities against HSV-1 or any virostatic activities on the growth of HSV-1 in Vero cells. These results suggest that TJS-109 protected mice exposed to lethal amounts of HSV-1 through the activation of CD8+ T cells.
AuthorsK Ikemoto, T Utsunomiya, M A Ball, M Kobayashi, R B Pollard, F Suzuki
JournalExperientia (Experientia) Vol. 50 Issue 5 Pg. 456-60 (May 15 1994) ISSN: 0014-4754 [Print] Switzerland
PMID7910798 (Publication Type: Journal Article)
Chemical References
  • CD8 Antigens
  • Drugs, Chinese Herbal
  • shigyaku-to
Topics
  • Animals
  • CD4-Positive T-Lymphocytes
  • CD8 Antigens (immunology)
  • Drugs, Chinese Herbal (therapeutic use, toxicity)
  • Herpes Simplex (immunology, prevention & control, therapy)
  • Herpesvirus 1, Human (drug effects, growth & development)
  • Immunotherapy, Adoptive
  • Lymphocyte Transfusion
  • Male
  • Mice
  • Mice, Inbred BALB C
  • T-Lymphocyte Subsets
  • Time Factors
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: